Aimei Health (NASDAQ: AFJKU) extends deadline to Oct 6 2025 via $150k note

Rhea-AI Filing Summary

Aimei Health Technology Co., Ltd deposited $150,000 into its trust account to extend the deadline to complete its initial business combination by one month, moving the termination date from September 6, 2025 to October 6, 2025. This is the tenth of up to 12 one‑month extensions allowed under its current Articles of Association.

To fund this extension, the company issued a $150,000 unsecured promissory note on September 5, 2025 to its sponsor, Aimei Health Ltd, and United Hydrogen Group Inc., with each contributing $75,000. The note bears no interest and becomes due when the company completes a business combination with United Hydrogen. The payees may instead convert the note into private units at $10.00 per unit, each unit consisting of one ordinary share and one right to receive one‑fifth of one ordinary share, immediately before the business combination closes.

false 0001979005 00-0000000 0001979005 2025-09-05 2025-09-05 0001979005 AFJK:OrdinarySharesParValue0.0001PerShareMember 2025-09-05 2025-09-05 0001979005 AFJK:RightsExchangeableIntoOnefifthOfOneOrdinaryShareMember 2025-09-05 2025-09-05 0001979005 AFJK:UnitsEachConsistingOfOneOrdinaryShareAndOneRightMember 2025-09-05 2025-09-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

United States

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 8-K

Current Report

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

September 5, 2025

Date of Report (Date of earliest event reported)

AIMEI HEALTH TECHNOLOGY CO., LTD

(Exact Name of Registrant as Specified in its Charter)

Cayman Islands		001-41880		N/A
(State or other jurisdiction of incorporation)		(Commission File Number)		(I.R.S. Employer Identification No.)

10 East 53rd Street, Suite 3001 New York, NY		10022
(Address of Principal Executive Offices)		(Zip Code)

86-13758131392

Registrant’s telephone number, including area code

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐	Written communications pursuant to Rule 425 under the Securities Act
☐	Soliciting material pursuant to Rule 14a-12 under the Exchange Act
☐	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act
☐	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act

Securities registered pursuant to Section 12(b) of the Act:

Title of each Class		Trading Symbol(s)		Name of each exchange on which registered
Ordinary Shares, par value $0.0001 per share		AFJK		The Nasdaq Stock Market LLC
Rights, exchangeable into one-fifth of one Ordinary Share		AFJKR		The Nasdaq Stock Market LLC
Units, each consisting of one Ordinary Share and one Right		AFJKU		The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

Extension of the Termination Date

An aggregate of $150,000 (the “Extension Payment”) has been deposited into the trust account of Aimei Health Technology Co., Ltd (the “Company”) for its public shareholders, which enables the Company to further extend the period of time it has to consummate its initial business combination by one month (the “Extension”) from September 6, 2025 to October 6, 2025 (the “Termination Date”). The Extension is the tenth of up to 12 extensions permitted under the Amended and Restated Articles of Association of the Company currently in effect.

Promissory Note

In connection with the Extension, the Company issued, on September 5, 2025 , an unsecured promissory note in the total principal amount of $150,000 (the “Promissory Note”) to Aimei Health Ltd, a Cayman Islands exempted company (the “Sponsor”) and United Hydrogen Group Inc., an exempted company with limited liability incorporated in the Cayman Islands (“United Hydrogen,” and together with the Sponsor, the “Payees”). The amount was equally divided between the Payees, with each contributing $75,000, to fund the Extension Payment. The Promissory Note does not bear interest and the principal thereunder becomes due and payable upon the date on which the Company consummates a business combination with United Hydrogen (the “Business Combination”). The Payees have the right, but not the obligation, to convert the Promissory Note, in whole or in part, into private units of the Company, at a price of $10.00 per unit, each consisting of one ordinary share and one right to receive one-fifth (1/5) of one ordinary share of the Company, immediately prior to the consummation of the Business Combination, by providing the Company with written notices of their intention to convert the Promissory Note at least two business days prior to the closing of the Business Combination.

The foregoing description of the Promissory Note is not complete and is qualified in its entirety by reference to the text of such document, which is filed as Exhibit 10.1 hereto and which is incorporated herein by reference.

Item 9.01 Exhibits.

(d) Exhibits

Exhibit No.		Description
10.1		Promissory Note, dated September 5, 2025, by and among Aimei Health Technology Co., Ltd, Aimei Health Ltd, and United Hydrogen Group Inc.
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: September 5, 2025

	Aimei Health Technology Co., Ltd
	By:	/s/ Junheng Xie
	Name:	Junheng Xie
	Title:	Chief Executive Officer and Director
		(Principal Executive Officer)

FAQ

What did Aimei Health Technology Co., Ltd (AFJKU) disclose in this 8-K?

Aimei Health Technology Co., Ltd disclosed that it extended the deadline to complete its initial business combination by one month to October 6, 2025 by depositing $150,000 into its trust account. It also described a related unsecured promissory note issued to its sponsor and United Hydrogen Group Inc. to fund this payment.

How is the SPAC extension for Aimei Health (AFJKU) being funded?

The one‑month extension is funded through a $150,000 unsecured promissory note issued on September 5, 2025 to Aimei Health Ltd and United Hydrogen Group Inc., with each payee contributing $75,000 to cover the extension payment into the trust account.

When does Aimei Health’s current SPAC termination date expire after this extension?

After this extension, the termination date for Aimei Health Technology Co., Ltd to consummate its initial business combination is October 6, 2025, extended from September 6, 2025.

What are the key terms of the $150,000 promissory note described by Aimei Health?

The $150,000 promissory note is unsecured, bears no interest, and its principal becomes due and payable when Aimei Health consummates a business combination with United Hydrogen Group Inc. The amount is split equally between the sponsor and United Hydrogen, at $75,000 each.

Can the Aimei Health promissory note be converted into equity, and if so, how?

Yes. The payees have the right, but not the obligation, to convert the promissory note, in whole or in part, into private units at a price of $10.00 per unit. Each unit consists of one ordinary share and one right to receive one‑fifth of one ordinary share, and conversion would occur immediately prior to the closing of the business combination, with written notice at least two business days before closing.

How many SPAC deadline extensions has Aimei Health used so far?

The company states this one‑month extension is the tenth of up to 12 extensions permitted under its current Amended and Restated Articles of Association.